Patient-Reported Outcome Version of the Common Term Criteria for Adverse Events
Showing 1 - 25 of >10,000
Version of the Common Criteria for Adverse Events
Recruiting
- Survivorship
- Cancer
- Childhood Cancer Survivors (CCSS)
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Cancer Trial in Kufstein (Patient-reported outcomes assessment, CTCAE rating, PRO data is displayed)
Recruiting
- Cancer
- Patient-reported outcomes assessment
- +2 more
-
Kufstein, AustriaBezirkskrankenhaus Kufstein
Apr 5, 2022
PRO-CTCAE for Adult-type Diffuse Gliomas Chinese Population
Not yet recruiting
- Glioma
- +3 more
-
Beijing, Beijing, China
- +16 more
Aug 4, 2022
Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of
Not yet recruiting
- Bladder Cancer
- +3 more
- Geriatric-8 Survey
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Tumors Trial in Seoul (ePRO-CTCAE application)
Active, not recruiting
- Neoplasms
- ePRO-CTCAE application
-
Seoul, Korea, Republic of
- +1 more
Jul 3, 2021
Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority
Recruiting
- Prostate Cancer
- +2 more
- Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
- +7 more
-
Quebec, CanadaCHUdeQuebec
Apr 7, 2023
Version of Common Terminology Criteria for Adverse Events Via
Completed
- Lymphomas
- +2 more
-
New York, New York
- +1 more
Jul 16, 2020
Testing a Spanish Version of a Patient Toxicity Questionnaire
Completed
- Breast Cancer
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI), 9000 Rockville Pike
Dec 13, 2019
Malignant Tumor Trial (Experimental: DaRT seeds)
Not yet recruiting
- Malignant Tumor
- Experimental: DaRT seeds
- (no location specified)
Mar 27, 2023
Validation of the Italian Version of the PRO-CTCAE
Recruiting
- Malignant Neoplasms
- PRO-CTCAE items
-
Bari, Italy
- +24 more
Mar 2, 2021
Hysterectomy, LAP Trial (On-line, multi-media information on a specifically designed website for Same Day Discharge following
Not yet recruiting
- Hysterectomy
- LAP
- On-line, multi-media information on a specifically designed website for Same Day Discharge following Laparoscopic Hysterectomy
- (no location specified)
Aug 21, 2023
Multiple Myeloma Trial (Continued treatment adapted to the response)
Completed
- Multiple Myeloma
- Continued treatment adapted to the response
- (no location specified)
Jan 14, 2023
Triple Negative Breast Cancer (TNBC) Trial in United States (Combination of liposomal doxorubicin)
Not yet recruiting
- Triple Negative Breast Cancer (TNBC)
- Combination of liposomal doxorubicin
-
Elizabeth, New Jersey
- +7 more
Jul 13, 2023
Radiation Dermatitis Trial in Miami (StrataXRT, Aquaphor)
Not yet recruiting
- Radiation Dermatitis
- StrataXRT
- Aquaphor
-
Miami, FloridaMiami Cancer Institute
Sep 29, 2022
A Disease Registry of Patients With Mantle Cell Lymphoma
Active, not recruiting
- Mantle Cell Lymphoma
-
Montgomery, Alabama
- +33 more
Oct 28, 2022
Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Cardiovascular Diseases
- Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Nassau, The Bahamas, BahamasThe Partners Clinical Research Centre at The Medical Pavilion
Oct 17, 2023
Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial
Recruiting
- Renal Cancer
- +2 more
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC locatie VUMC
Jan 20, 2023
After Oncoplastic Breast Conserving Surgery
Not yet recruiting
- Breast Cancer Stage I
- +2 more
- Breast-conserving surgery
- (no location specified)
Feb 2, 2023
Ultra-hypofractionated Radiotherapy in Breast Cancer Patients
Recruiting
- Female Breast Cancer
- ultra-hypofractionated whole breast irradiation
-
Perugia, ItalyRadiation Oncology Section, Department of Medicine and Surgery,
Oct 16, 2022
Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced
Completed
- Oral Cancer
- PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital
Nov 20, 2023
Nasopharyngeal Carcinoma Post IMRT
Active, not recruiting
- Nasopharyngeal Carcinoma
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Cancer Centre
Apr 14, 2022
Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)
Not yet recruiting
- Muscle Invasive Bladder Urothelial Carcinoma
- Daily Adaptive External Beam Radiation Therapy
-
Saint Louis, MissouriWashington University, St. Louis
Jan 17, 2023
Ankle Injuries, Instability, Joint Trial in Eskisehir (Cumberland ankle instability tool for diagnose to determine ankle
Recruiting
- Ankle Injuries
- Instability, Joint
- Cumberland ankle instability tool for diagnose to determine ankle instability and its severity
-
Eskişehir, Tepebaşı, TurkeyEskişehir Technical University
Jul 28, 2023
Colo-rectal Cancer, Neuropathy;Peripheral, Mucositis Trial in Tanta (Pentoxifylline, Placebo, FOLFOX-6 regimen)
Enrolling by invitation
- Colo-rectal Cancer
- +2 more
- Pentoxifylline
- +2 more
-
Tanta, Gharbyia, EgyptTanta University
Oct 18, 2022
Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- Adaptive Radiotherapy
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 3, 2022